Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Beleave Inc BLEVF

Beleave Inc is a vertically integrated Canadian cannabis company. It operates streamlined facilities throughout Canada to cultivate high quality cannabis flower, oil and extracts with funded capacity more than 150,000 kilograms per year. Fully licensed to cultivate and sell medical and recreational cannabis, it is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. The company is currently developing new product lines as the recreational market is expected to allow for food and beverage-based cannabis products.


GREY:BLEVF - Post by User

Bullboard Posts
Post by yorgosGKon May 17, 2018 11:21am
69 Views
Post# 28045741

Very key entry in the MD&A

Very key entry in the MD&A

Very key entry on page 16 of their most recent MD&A. Even at $3.00 BE is obviously very profitable to them. I mean when you add the cash on hand (currently) a long with realestate and all assets - its undervalued even at $2.00. Its simple math. Imagin a correction with ANY sort of earnings :o . This one is EASY folks. I have done my DD - Impressive. 


On January 4, 2018, the Company granted 1,350,000 stock options to purchase Common Shares to the directors and management team in accordance with the Company's stock option plan. Each option is exercisable to purchase one Common Share at $3.00 per Common Share. All options vest immediately and have a five-year term.

 
Bullboard Posts